Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-01, Stock:JNJ, The news for the past five days is as follows:
2018-09-24: NEWS1: J&J&apos;s Esketamine Fails to Meet Endpoint in Phase III Study.NEWS2: J&J Talc Cancer Case Ends in Mistrial With Divided Jury.NEWS3: Why Geron Corporation Stock Is Bolting Higher Today.NEWS4: Why Geron Corporation Stock Is Bolting Higher Today.NEWS5: AstraZeneca's Diabetes Treatment Reduces Cardiovascular Risk.NEWS6: AstraZeneca's Diabetes Treatment Reduces Cardiovascular Risk.NEWS7: Why Geron Corporation Stock Is Bolting Higher Today.NEWS8: AstraZeneca&apos;s Diabetes Treatment Reduces Cardiovascular Risk.NEWS9: Johnson & Johnson Might Be Tempted to Buy These 2 Device Makers.
2018-09-25: NEWS1: Top Research Reports for Johnson & Johnson, Visa & Verizon.NEWS2: Top Research Reports for Johnson & Johnson, Visa & Verizon.NEWS3: Sponsorship spending to hit $66 billion worldwide, but most firms don&apos;t know if it really works.NEWS4: Top Research Reports for Johnson & Johnson, Visa & Verizon.NEWS5: Market Opportunities for J&J’s Depression Drug, Esketamine.NEWS6: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS7: Allergan’s Stock Price Performance in September.NEWS8: How J&J Has Expanded Its Orthopedics Business.NEWS9: Bull of the Day: Penumbra (PEN).NEWS10: Bull of the Day: Penumbra (PEN).NEWS11: Bull of the Day: Penumbra (PEN).NEWS12: J&J's Esketamine Fails to Meet Endpoint in Phase III Study.NEWS13: J&J's Esketamine Fails to Meet Endpoint in Phase III Study.
2018-09-26: NEWS1: Successful Investing Hinges on Understanding Risk and Return.NEWS2: Successful Investing Hinges on Understanding Risk and Return.NEWS3: Glaxo's Tuberculosis Vaccine Positive in Mid-Stage Study.NEWS4: Glaxo's Tuberculosis Vaccine Positive in Mid-Stage Study.NEWS5: What’s Driving Pfizer’s Revenue?.NEWS6: Successful Investing Hinges on Understanding Risk and Return.NEWS7: The Zacks Analyst Blog Highlights: Johnson & Johnson, Visa, Verizon, Alphabet and Altria.NEWS8: The Zacks Analyst Blog Highlights: Johnson & Johnson, Visa, Verizon, Alphabet and Altria.NEWS9: J&J exec: Tuberculosis is a global emergency. It's time to start treating it that way..NEWS10: Prestige Consumer Healthcare Inc. (PBH) Ex-Dividend Date Scheduled for September 27, 2018.NEWS11: Prestige Consumer Healthcare Inc. (PBH) Ex-Dividend Date Scheduled for September 27, 2018.NEWS12: What Johnson & Johnson Expects for Xarelto.NEWS13: The Zacks Analyst Blog Highlights: Johnson & Johnson, Visa, Verizon, Alphabet and Altria.NEWS14: Opportunities and Competition for J&J’s Blockbuster Drug, Xarelto.NEWS15: Market Morning: Treasury Bear, Fed Fuss, Square FANGAS, And Dunkin’ Not Donuts.NEWS16: DAX Subdued Ahead Of Fed Decision.NEWS17: DAX Subdued Ahead Of Fed Decision.
2018-09-27: NEWS1: Allergan Eyes Vraylar Label Expansion, FDA Accepts sNDA.NEWS2: Allergan Eyes Vraylar Label Expansion, FDA Accepts sNDA.NEWS3: A Look at Abbott Laboratories’ Valuation Trend.NEWS4: Why Bed Bath & Beyond, Geron, and Canopy Growth Slumped Today.NEWS5: Markets Right Now: Technology leads gains for US stocks.NEWS6: Analysts’ Most Recent Recommendations on ABT.NEWS7: Allergan Eyes Vraylar Label Expansion, FDA Accepts sNDA.NEWS8: Geron Stock Plunges After Johnson & Johnson Ends Collaboration Deal.NEWS9: Geron Stock Plunges After Johnson & Johnson Ends Collaboration Deal.NEWS10: Markets Right Now: Apple, Amazon lead stocks slightly higher.NEWS11: Fund gives J&J, Oxford experts $19 mln to fight deadly viruses.NEWS12: Why Geron Corporation's Stock Is Getting Hammered Today.NEWS13: Why Geron Corporation's Stock Is Getting Hammered Today.NEWS14: Wall Street Set For Gains After Fed Rate Hike, Q2 GDP Growth Steady at 4.2%.NEWS15: Wall Street Set For Gains After Fed Rate Hike, Q2 GDP Growth Steady at 4.2%.NEWS16: US Futures Point North After Fed Rate Hike; Data in Focus.NEWS17: US Futures Point North After Fed Rate Hike; Data in Focus.NEWS18: [$$] Stock of China's GenScript Plummets on Report Critical of Unit's Gene-Therapy Tests.NEWS19: Geron Plunges 68% After J&J Ends Partnership That Had Ignited Stock.NEWS20: The Daily Biotech Pulse: Hologic Goes Shopping, Johnson & Johnson Snaps Ties With Geron.NEWS21: Shares of biotech firm Geron fall 70% after Johnson & Johnson ends collaboration.NEWS22: Why Geron Corporation&apos;s Stock Is Getting Hammered Today.NEWS23: Assessing Pfizer’s Global Performance.
2018-09-28: NEWS1: Johnson & Johnson (JNJ) Stock Moves -0.04%: What You Should Know.NEWS2: Johnson & Johnson (JNJ) Stock Moves -0.04%: What You Should Know.NEWS3: Johnson & Johnson (JNJ) Stock Moves -0.04%: What You Should Know.NEWS4: Close Update: Wall Street Caps Strong Third Quarter as Friday Fizzles.NEWS5: Close Update: Wall Street Caps Strong Third Quarter as Friday Fizzles.NEWS6: Why Geron Corporation's Stock Is Sinking, Again.NEWS7: Why Geron Corporation's Stock Is Sinking, Again.NEWS8: Mid-Day Update: Stocks Reverse Early Losses as Technical Support Holds, Italy Fades Into Bankground.NEWS9: Mid-Day Update: Stocks Reverse Early Losses as Technical Support Holds, Italy Fades Into Bankground.NEWS10: Johnson and Johnson May Rise 7% Amid Strong Growth.NEWS11: Women Health a Prime Concern Worldwide: 3 Stocks in Focus.NEWS12: Women Health a Prime Concern Worldwide: 3 Stocks in Focus.NEWS13: Why Geron Corporation&apos;s Stock Is Sinking, Again.NEWS14: Geron's Stock Plunges as J&J Ends Imetelstat Collaboration.NEWS15: Geron's Stock Plunges as J&J Ends Imetelstat Collaboration.NEWS16: Can Geron Corporation Recover From Its Breakup With Johnson & Johnson?.NEWS17: Can Geron Corporation Recover From Its Breakup With Johnson & Johnson?.NEWS18: EW Traded at Its 52-Week High on September 28.NEWS19: After Its Disastrous Day, What's Next for Geron Corp.?.NEWS20: After Its Disastrous Day, What's Next for Geron Corp.?.NEWS21: Geron&apos;s Stock Plunges as J&J Ends Imetelstat Collaboration.NEWS22: Wall Street Falls in Sympathy With Europe As Italian Budget Crisis Spooks Investors.NEWS23: Wall Street Falls in Sympathy With Europe As Italian Budget Crisis Spooks Investors.NEWS24: Can Geron Corporation Recover From Its Breakup With Johnson & Johnson?.NEWS25: After Its Disastrous Day, What&apos;s Next for Geron Corp.?.NEWS26: Comparing Pfizer Stock and Johnson & Johnson Stock.NEWS27: Technical Indicators for Pfizer Stock’s Movements.NEWS28: Better Buy: Geron Corporation vs. Incyte Corporation.NEWS29: Better Buy: Geron Corporation vs. Incyte Corporation.NEWS30: Better Buy: Geron Corporation vs. Incyte Corporation.NEWS31: [$$] China’s Genscript jumps after denying faking allegations.

Answer: Rise